wujia yizhi granules (KH110)
/ Chengdu Kanghong Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 15, 2024
Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)
(clinicaltrials.gov)
- P3 | N=570 | Recruiting | Sponsor: Sichuan Jishengtang Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders • Dementia
August 02, 2024
Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)
(clinicaltrials.gov)
- P3 | N=570 | Not yet recruiting | Sponsor: Sichuan Jishengtang Pharmaceutical Co., Ltd.
New P3 trial • Alzheimer's Disease • CNS Disorders • Dementia
1 to 2
Of
2
Go to page
1